Image For Activity Cover
Current and Future State of Cardiovascular Disease and Type 2 Diabetes
Course Description

This three-part series focuses on the optimal management of type 2 diabetes in the context of cardiovascular disease. The educational programs focus on current evidence-based practice for primary care clinicians treating patients as they progress from early-stage to advancing to late-stage disease.

Together with the the American Academy of Family Physicians (AAFP), the American Association of Nurse Practitioners (AANP), and the American Academy of PAs (AAPA), the Endocrine Society has created this Resource Center for more information.  

Learning Objectives

Case 1

  • Discuss the epidemiology of prediabetes and diabetes
  • Review risk factors, screening tools and diagnostic criteria for prediabetes and diabetes
  • Describe the pathophysiology and complications of prediabetes
  • Analyze the relationship between prediabetes and cardiovascular disease
  • Develop and implement screening strategies for a patient presenting with prediabetes
  • Formulate an evidence-based treatment plan for patients with prediabetes including lifestyle and pharmacologic interventions 

Case 2

  • Discuss prevalence and associations of diabetes, cardiovascular disorders (CVD), and diabetic kidney disease (DKD)
  • Recognize diabetes as a CVD equivalent and accelerator
  • Review behavioral interventions for mitigating CVD and DKD risk in type 2 diabetes mellitus (T2DM)
  • Distinguish major drug classes and outcomes from cardiovascular outcome trials (CVOTs) related to impacts on glycemic control, CVD and DKD risk reduction in T2DM
  • Develop clinical strategies using CVOT drug classes to optimize glycemic goals and reduce CVD and DKD risk for patients with T2DM
  • Implement a team approach to diabetes care encouraging patient-centered diabetes self-management skills, education and support (DSMES)

Case 3

  • Review major risk factors for coronary artery disease, diabetic kidney disease and heart failure in patients with type 2 diabetes
  • Summarize the associations of type 2 diabetes, CVD and DKD and implications to the progression of cardiorenal syndrome (CRS) and CV mortality
  • Apply CVOT results to provide guidance on appropriate pharmacologic interventions for patients with advanced diabetes related complications
  • Analyze the impact of hypoglycemia in patients with advanced coronary artery disease and discuss techniques for mitigating risk of hypoglycemia
  • Employ tools and techniques to improve adherence and long-term chronic disease outcomes
Accreditation Statement

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the Endocrine Society, the American Academy of Family Physicians (AAFP), the American Association of Nurse Practitioners (AANP), and the American Academy of PAs (AAPA). 

The Endocrine Society is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. Endocrine Society has achieved Accreditation with Commendation.

AMA PRA Category 1 Credit
The Endocrine Society designates each activity in this course for a maximum of 3.00 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. While offering CME credits noted above, this program is not intended to provide extensive training or certification in the field.

Please note that while other accrediting bodies accept AMA PRA Category 1 credit, we can only award and report this credit for MDs/DOs. For those outside of this accreditation, please complete the participation evaluation and use that certificate as proof of attendance to submit to your accrediting body.

Maintenance of Certification (MOC) - if eligible
Successful completion of each CME activity in this course, which includes participation in the evaluation component, enables the participant to earn up to 3.00 points in the American Board of Internal Medicine (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

For questions about content or obtaining CME credit, please contact the Endocrine Society at

Faculty and Disclosures

As a provider of CME accredited by the Accreditation Council for Continuing Medical Education, the Endocrine Society has a policy of ensuring that the content and quality of this educational activity are balanced, independent, objective, and scientifically rigorous. The scientific content of this activity was developed under the supervision of the Endocrine Society’s guideline task force.

The faculty, committee members, and staff who are in position to control the content of this activity are required to disclose to the Endocrine Society and to learners any relevant financial relationship(s) of the individual or spouse/partner that have occurred within the last 12 months with any commercial interest(s) whose products or services are related to the CME content. Financial relationships are defined by remuneration in any amount from the commercial interest(s) in the form of grants; research support; consulting fees; salary; ownership interest (e.g., stocks, stock options, or ownership interest excluding diversified mutual funds); honoraria or other payments for participation in speakers' bureaus, advisory boards, or boards of directors; or other financial benefits. The intent of this disclosure is not to prevent CME planners with relevant financial relationships from planning or delivery of content, but rather to provide learners with information that allows them to make their own judgments of whether these financial relationships may have influenced the educational activity with regard to exposition or conclusion.

The following faculty reported no relevant financial relationships: Jonathan Weber, MA, PA-C

The following faculty reported  relevant financial relationships during the content development process for this activity: 

  • Jonathan Purnell, MD Consultant, Advisory Board Member, Novo Nordisk
  • Angela Thompson, DNP Consultant, Focus Group, Novo Nordisk
  • Jeff Unger, MD, FAAFP,  FACE Consultant, Speaker, Advisory Board Member, Primary Investigator, Novo Nordisk; Consultant, Advisory Board Member, Speaker, Abbott Diabetes; Speaker, Allergan

The following SPC member who planned and reviewed content for this activity reported no relevant financial relationships:  Beret Anne Casey, MD

The following SPC Committee members reported financial relationships:

  • Andjela T. Drincic, MD: Advisory Board Member, Corcept
  • Sergio Fazio, MD, PhD: Consultant, Amarin, Amgen, Akcea, Aegerion, Esperion, Novartis
  • Angela M. Leung, MD: Speaker, Medical Education Resources, MCE Conferences, ATA Board Member
  • Amy Rothberg, MD: Spouse, consultant of Merck
  • Katherine Araque, MD: Speaker, Novo Nordisk; Advisory Board, Corcept

The Endocrine Society has reviewed these relationships to determine which are relevant to the content of this activity and resolved any identified conflicts of interest for these individuals.

The following SPC members reported no relevant financial relationships:

Lorena Alarcon-Casas Wright, MD, Neena Natt, MD; Kelly Lauter Roszko, MD, PhD; Deborah Sellmeyer, MD; Savitha Subramanian, MD; Soleymani Taraneh, MD; Steven Weitzman, MD

The Endocrine Society staff associated with the development of content for this activity reported no relevant financial relationships.

The Endocrine Society staff have reviewed all disclosures and resolved or managed all relevant identified conflicts of interest, as applicable.


This educational activity is supported by independent medical educational grants from Boehringer Ingelheim Pharmaceuticals, Inc., Lilly USA, LLC, and Novo Nordisk.

Availability: On-Demand
Available Nov 12, 2020 to Dec 31, 2021
Cost: FREE
Credit Offered:
3 AMA PRA Category 1 Credits
3 ABIM-MOC Points
3 Participation Credits
Contains: 3 Courses
     EndoCareers | Contact Us | Privacy Policy | Terms of Use CONNECT WITH US                
       © 2021 Copyright Endocrine Society. All rights reserved.
2055 L Street NW, Suite 600 | Washington, DC 20036      
 202.971.3636 | 888.363.6274
Powered By